The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -52.21%. However, over the past six months, we’ve seen a stronger performance of -25.20%. The price of TXG leaped by -25.95% over the last 30 days. And in the last five days, it has fallen by -2.83%.
The stock market performance of 10x Genomics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $63.57 on 07/31/23, while the lowest price during the same time frame was $26.30, recorded on 05/01/24.
52-week price history of TXG Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. 10x Genomics Inc’s current trading price is -57.94% away from its 52-week high, while its distance from the 52-week low is 1.68%. The stock’s price range for this period has been between $26.30 and $63.57. The Healthcare sector company’s shares saw a trading volume of about 2.24 million for the day, which was higher than the average daily volume of 1.46 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
10x Genomics Inc (TXG) has experienced a quarterly decline of -35.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.20B and boasts a workforce of 1259 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 42.72, with a change in price of -19.18. Similarly, 10x Genomics Inc recorded 1,410,243 in trading volume during the last 100 days, posting a change of -41.52%.
TXG’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TXG stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.11.
TXG Stock Stochastic Average
As of today, the raw stochastic average of 10x Genomics Inc over the past 50 days is 10.16%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 18.42%. Additionally, the Stochastic %K and %D values for the company were 20.95% and 16.99%, respectively, over the past 20 days.
